Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARIX BIOSCIENCE PLC Director's Dealing 2021

Dec 17, 2021

4968_dirs_2021-12-17_54467958-c3b7-4974-a644-229b2fcd998a.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9556V

Arix Bioscience Plc

17 December 2021

Arix Bioscience plc

Director/PDMR Shareholdings

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Robert Lyne
2 Reason for the notification
a) Position/status CEO and General Counsel
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
120.00p 41,666.00
d) Aggregated information
- Aggregated volume N/A single transaction
- Price £49,999.20
e) Date of the transaction 16 December 2021
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Peregrine Moncreiffe
2 Reason for the notification
a) Position/status Non-Executive Director and Chair of the Board
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
119.00p 84,000.00
d) Aggregated information
- Aggregated volume N/A single transaction
- Price £99,959.98
e) Date of the transaction 16 December 2021
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Sir Michael Bunbury
2 Reason for the notification
a) Position/status Non-Executive Director and Senior Independent Director (SID)
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
119.00p 40,000.00
d) Aggregated information
- Aggregated volume N/A single transaction
- Price £47,600.00
e) Date of the transaction 16 December 2021
f) Place of the transaction London Stock Exchange

For further information please contact:

Derringtons Limited, Company Secretary

+44 20 8819 6486

Ends.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDQLFFFLLXFBQ